The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffoldBONN, Peter; BRINK, D. Mikael; FÄGERHAG, Jonas et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 24, pp 7302-7305, issn 0960-894X, 4 p.Article

Determination of Specific Absorbance (Al) for Zaleplon (Sonata^®) by SpectrophotometryANDERSON, Daniel T; ELBOGEN, Julie L.Journal of analytical toxicology. 2009, Vol 33, Num 8, pp 478-480, issn 0146-4760, 3 p.Article

Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol DosingHERSHFIELD, M. S; CALLAGHAN, J. T; TASSANEEYAKUL, W et al.Clinical pharmacology and therapeutics. 2013, Vol 93, Num 2, pp 153-158, issn 0009-9236, 6 p.Article

A double-blind trial of adjunctive allopurinol for schizophreniaDICKERSON, Faith B; STALLINGS, Cassie R; ORIGONI, Andrea E et al.Schizophrenia research. 2009, Vol 109, Num 1-3, pp 66-69, issn 0920-9964, 4 p.Article

Toxidermies à l'allopurinolGRENIER, Antoine.La Revue du praticien. Médecine générale. 2012, Num 891, issn 0989-2737, p. 829Article

Fluorescence emission properties of 8-aza analogues of caffeine, theophylline, and related N-alkyl xanthinesMEDZA, Grzegorz; WIERZCHOWSKI, Jacek; KIERDASZUK, Borys et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 6, pp 2585-2591, issn 0968-0896, 7 p.Article

Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labourKAANDORP, J. J; VAN DEN BROEK, M. P. H; MOL, B. W. J et al.Archives of disease in childhood. Fetal and neonatal edition. 2014, Vol 99, Num 2, issn 1359-2998, F144-F148Article

An Audit of a Therapeutic Drug Monitoring Service for Allopurinol TherapyKANNANGARA, Diluk R. W; RAMASAMY, Sheena N; RAY, John E et al.Therapeutic drug monitoring. 2013, Vol 35, Num 6, pp 863-866, issn 0163-4356, 4 p.Article

GABA_A receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplonWEGNER, Florian; DEUTHER-CONRAD, Winnie; STEINBACH, Jörg et al.European journal of pharmacology. 2008, Vol 580, Num 1-2, pp 1-11, issn 0014-2999, 11 p.Article

Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: Incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabiltyBASARAB, Gregory S; HILL, Pamela; EYERMANN, Charles J et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 17, pp 5600-5607, issn 0960-894X, 8 p.Article

Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf^V600E kinase with favorable physicochemical and pharmacokinetic propertiesLI REN; LAIRD, Ellen R; RUDOLPH, Joachim et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 2, pp 1165-1168, issn 0960-894X, 4 p.Article

Meta-analysis : allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitisBAI, Y; GA, J; ZHANG, W et al.Alimentary pharmacology & therapeutics. 2008, Vol 28, Num 5, pp 557-564, issn 0269-2813, 8 p.Article

The Role of Urate and Xanthine Oxidase Inhibitors in Cardiovascular DiseaseGEORGE, Jacob; STRUTHERS, Allan D.Cardiovascular therapeutics (Print). 2008, Vol 26, Num 1, pp 59-64, issn 1755-5914, 6 p.Article

Virtual Screening to Successfully Identify Novel Janus Kinase 3 Inhibitors : A Sequential Focused Screening ApproachXIN CHEN; WILSON, Lawrence J; MALAVIYA, Ravi et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 21, pp 7015-7019, issn 0022-2623, 5 p.Article

Different Metabolites of Human Hepatotoxic Pyrazolopyrimidine Derivative 5-n-Butyl-Pyrazolo[1,5-a]Pyrimidine Produced by Human, Rat and Monkey Cytochrome P450 1A2 and Liver MicrosomesKURIBAYASHI, Shunji; UNO, Yasuhiro; NAITO, Shinsaku et al.Basic & clinical pharmacology & toxicology (Print). 2012, Vol 110, Num 4, pp 405-408, issn 1742-7835, 4 p.Article

Impact of allopurinol use on urate concentration and cardiovascular outcomeLI WEI; MACKENZIE, Isla S; YANG CHEN et al.British journal of clinical pharmacology. 2011, Vol 71, Num 4, pp 600-607, issn 0306-5251, 8 p.Article

In situ absorption and relative bioavailability studies of zaleplon loaded self-nanoemulsifying powdersJANGA, Karthik Y; JUKANTI, Raju; SUNKAVALLI, Sharath et al.Journal of microencapsulation. 2013, Vol 30, Num 2, pp 161-172, issn 0265-2048, 12 p.Article

InCl₃-catalysed synthesis of 2-aryl quinazolin-4(3H)-ones and 5-aryl pyrazolo[4,3-d]pyrimidin-7(6H)-ones and their evaluation as potential anticancer agentsMULAKAYALA, Naveen; KANDAGATLA, Bhaskar; ISMAIL et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 15, pp 5063-5066, issn 0960-894X, 4 p.Article

Patch testing in fixed drug eruptions-a 20-year reviewANDRADE, Pedro; BRINCA, Ana; GONCALO, Margarida et al.Contact dermatitis. 2011, Vol 65, Num 4, pp 195-201, issn 0105-1873, 7 p.Article

Allopurinol Reduces Oxidative Stress in the Ovine Fetal Cardiovascular System After Repeated Episodes of Ischemia-ReperfusionDERKS, Jan B; OUDIJK, Martijn A; VAN BEL, Frank et al.Pediatric research. 2010, Vol 68, Num 5, pp 374-380, issn 0031-3998, 7 p.Article

Association between allopurinol and mortality in heart failure patients: a long-term follow-up studyWEI, L; FAHEY, T; STRUTHERS, A. D et al.International journal of clinical practice (Esher). 2009, Vol 63, Num 9, pp 1327-1333, issn 1368-5031, 7 p.Article

Pharmacokinetic and Pharmacodynamic Interaction between Allopurinol and Probenecid in Healthy SubjectsSTOCKER, Sophie L; WILLIAMS, Kenneth M; MCLACHIAN, Andrew J et al.Clinical pharmacokinetics. 2008, Vol 47, Num 2, pp 111-118, issn 0312-5963, 8 p.Article

Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitorsBUSSENIUS, Joerg; ANAND, Neel K; DUBENKO, Larisa et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 6, pp 2283-2286, issn 0960-894X, 4 p.Article

N-(2-mercaptopropionyl)-glycine but not Allopurinol prevented cigarette smoke-induced alveolar enlargement in mousePEREIRA PIRES, Karla Maria; SILVA BEZERRA, Frank; NASCIMENTO MACHADO, Mariana et al.Respiratory physiology & neurobiology. 2011, Vol 175, Num 3, pp 322-330, issn 1569-9048, 9 p.Article

Elevated Levels of Asymmetric Dimethylarginine in Chronic Heart Failure: A Pathophysiologic Link Between Oxygen Radical Load and Impaired Vasodilator Capacity and the Therapeutic Effect of AllopurinolVON HAEHLING, S; BODE-BÖGER, S. M; MARTENS-LOBENHOFFER, J et al.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 4, pp 506-512, issn 0009-9236, 7 p.Article